View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Novo Nordisk Pharmatech|16 April 2014

FeF® Benzalkonium Chloride (3% C16) USP/NF (BKC/BAC/BAK)

CAS No. 8001-54-5. Custom design product consisting of Benzyl (dodecyl) dimethyl ammonium chloride (approximately 64%), Benzyl (tetradecyl) dimethyl ammonium chloride (approximately 34%) and Benzyl (hexadecyl) dimethyl ammonium chloride (approximately 2%-3%). Contains approximately 95% active ingredients.

bkc 3%

CAS No. 8001-54-5. Custom design product consisting of Benzyl (dodecyl) dimethyl ammonium chloride (approximately 64%), Benzyl (tetradecyl) dimethyl ammonium chloride (approximately 34%) and Benzyl (hexadecyl) dimethyl ammonium chloride (approximately 2%-3%). Contains approximately 95% active ingredients.

Manufactured in accordance with the cGMP Guideline ICH Q7 for Active Pharmaceutical Ingredients.

Analyzed according to the current United States Pharmacopoeia (USP/NF).

Packaging sizes:

  •  Item number: 8160008U, 5kg pail

Documentation and services:

  • GMP Certificate
  • Certificate of Analysis (current version of pharmacopoeia)
  • Datasheet
  • Customer audits of FeF Chemicals’ plant
  • Stability and stress test results
  • Declarations, statements (TSE/BSE, residual solvents, GMO, allergens, environment, animal testing, etc.)
  • Change Notification Statement
  • Answering of questionnaires
  • Methods of analysis (FeF SOP)
  • Impurity profile
  • Description of the manufacturing process
  • Process flowchart
  • Packaging details
  • MSDS
  • ISO:9001 Certificate

For more than 30 years, the National Research Council of Canada has been helping clients develop, optimise, scale-up and transfer bioprocesses to produce biologics and...
The Chinese hamster ovary (CHO) cell line is widely used for the production of recombinant proteins due to its high growth capacity and productivity, as...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology